Literature DB >> 23957703

Immunohistochemical expressions of adropin and ınducible nitric oxide synthase in renal tissues of rats with streptozotocin-ınduced experimental diabetes.

T Kuloglu1, S Aydin.   

Abstract

Diabetes is characterized by high blood glucose levels; it occurs in 30-35% of the population. Elevated glucose levels can damage a number of organs, including the kidneys. Several peptide hormones participate in maintaining glucose homeostasis including the recently discovered "adropin," a 42 amino acid peptide hormone. Adropin also alters inducible nitric oxide synthase (iNOS) expression. Therefore, we studied how adropin and iNOS expression is altered in the renal tissues of streptozotocin (STZ) induced diabetic rats. Seven sham, seven control and seven Wistar albino male rats were fed standard rat pellets and water ad libitum for 10 weeks. The rats in the diabetic group were injected i.p. with a single dose of 60 mg/kg STZ dissolved in 0.1 M phosphate-citrate buffer, pH 4.5. After the 10-week experimental period, the rats in both groups were anesthetized and decapitated. Kidney tissues were excised and placed in 10% formaldehyde solution, taken through routine histological procedures, and embedded in paraffin. Sections 5-6 μm thick were stained immunohistochemically using the avidin-biotin complex (ABC) method. Adropin and iNOS immunoreactivity were co-localized in the glomeruli, peritubular interstitial cells and peritubular capillary endothelium of the cortex; the thin limb of the loop of Henle in the medulla; and medullary peritubular interstitial cells and endothelium of the peritubular capillaries in both the control and diabetic groups. The intensities of adropin and iNOS immunoreactivity increased with the severity of the diabetes. Intense adropin immunoreactivity was detected in both the smooth muscle and human small intestine Paneth cells that were used as positive controls. The elevated levels of adropin and iNOS in the kidney indicates that these substances are involved in the pathophysiology of diabetes; this constitutes a compensatory mechanism against the damage inflicted by the disease.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23957703     DOI: 10.3109/10520295.2013.821713

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  15 in total

1.  Expression of adropin in rat brain, cerebellum, kidneys, heart, liver, and pancreas in streptozotocin-induced diabetes.

Authors:  Suleyman Aydin; Tuncay Kuloglu; Suna Aydin; Mehmet Nesimi Eren; Musa Yilmaz; Mehmet Kalayci; Ibrahim Sahin; Nevin Kocaman; Cihan Citil; Yalcin Kendir
Journal:  Mol Cell Biochem       Date:  2013-04-26       Impact factor: 3.396

2.  Molecular cloning, characterization and expression of the energy homeostasis-associated gene in piglet.

Authors:  Sheng-ping Wang; Yun-ling Gao; Gang Liu; Dun Deng; Rong-jun Chen; Yu-zhe Zhang; Li-li Li; Qing-qi Wen; Yong-qing Hou; Ze-meng Feng; Zhao-hui Guo
Journal:  J Zhejiang Univ Sci B       Date:  2015-06       Impact factor: 3.066

3.  Antioxidant diet and sex interact to regulate NOS isoform expression and glomerular mesangium proliferation in Zucker diabetic rat kidney.

Authors:  Yuriy Slyvka; Ramiro Malgor; Sharon R Inman; Julia Ding; Victor Heh; Felicia V Nowak
Journal:  Acta Histochem       Date:  2016-01-18       Impact factor: 2.479

4.  Protective effects of vitamin C and vitamin E against hysterosalpingography-induced epithelial degeneration and proliferation in rat endometrium.

Authors:  Şehmus Pala; Remzi Atilgan; Tuncay Kuloğlu; Murat Kara; Melike Başpinar; Behzat Can; Gökhan Artaş
Journal:  Drug Des Devel Ther       Date:  2016-12-15       Impact factor: 4.162

Review 5.  Adropin- A Novel Biomarker of Heart Disease: A Systematic Review Article.

Authors:  Somaye Yosaee; Sepideh Soltani; Eghbal Sekhavati; Shima Jazayeri
Journal:  Iran J Public Health       Date:  2016-12       Impact factor: 1.429

6.  Serum adropin as a predictive biomarker of erectile dysfunction in coronary artery disease patients.

Authors:  Hüsetin Tugrul Celik; Mehmet Bilen; Fatmanur Kazancı; Mehmet Erol Yildirim; İlkay Bekir İncebay; Hüsamettin Erdamar
Journal:  Cent European J Urol       Date:  2019-07-08

7.  The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia.

Authors:  Raziye Akcılar; Fatma Emel Koçak; Hasan Şimşek; Aydın Akcılar; Zeynep Bayat; Ezgi Ece; Hülya Kökdaşgil
Journal:  Iran J Basic Med Sci       Date:  2016-03       Impact factor: 2.699

8.  Association of Serum Adropin Concentrations with Diabetic Nephropathy.

Authors:  Wenchao Hu; Li Chen
Journal:  Mediators Inflamm       Date:  2016-07-28       Impact factor: 4.711

9.  Adropin as a potential marker of enzyme-positive acute coronary syndrome.

Authors:  Suna Aydin; Mehmet Nesimi Eren; Musa Yilmaz; Mehmet Kalayci; Meltem Yardim; Omer Dogan Alatas; Tuncay Kuloglu; Huseyin Balaban; Tolga Cakmak; Mehmet Ali Kobalt; Ahmet Çelik; Suleyman Aydin
Journal:  Cardiovasc J Afr       Date:  2016-05-19       Impact factor: 1.167

10.  Inverse Correlation Between Plasma Adropin and ET-1 Levels in Essential Hypertension: A Cross-Sectional Study.

Authors:  Xiaosong Gu; Hui Li; Xinyi Zhu; Haibo Gu; Jianchang Chen; Luchen Wang; Pamela Harding; Weiting Xu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.